Literature DB >> 12408804

Receptor-dependent and tyrosine phosphatase-mediated inhibition of GSK3 regulates cell fate choice.

Leung Kim1, Adrian Harwood, Alan R Kimmel.   

Abstract

Asymmetric body axis formation is central to metazoan development. Dictyostelium establishes an anterior/posterior axis utilizing seven-transmembrane cAMP morphogen receptors (CARs) and GSK3-mediated signal transductions that has a parallel with metazoan Wnt/Frizzled-GSK3 pathways. In Dictyostelium, GSK3 promotes posterior cell patterning but inhibits anterior cell differentiation. Tyrosine kinase ZAK1 mediates GSK3 activation. We now show that CAR4 regulates a tyrosine phosphatase that inhibits GSK3 activity. We have also identified essential phosphotyrosines in GSK3, confirmed their role in activated/deactivated regulation and cell fate decisions, and relate them to the predicted 3D structure of GSK3beta. CARs differentially regulate GSK3 activity by selectively activating a tyrosine phosphatase or kinase for pattern formation. The findings may provide a comparative understanding of CAR-GSK3 and Wnt/Frizzled-GSK3 pathways.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12408804     DOI: 10.1016/s1534-5807(02)00269-1

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  30 in total

Review 1.  GSK-3: tricks of the trade for a multi-tasking kinase.

Authors:  Bradley W Doble; James R Woodgett
Journal:  J Cell Sci       Date:  2003-04-01       Impact factor: 5.285

2.  Combinatorial cell-specific regulation of GSK3 directs cell differentiation and polarity in Dictyostelium.

Authors:  Leung Kim; Joseph Brzostowski; Amit Majithia; Nam-Sihk Lee; Vanessa McMains; Alan R Kimmel
Journal:  Development       Date:  2011-02       Impact factor: 6.868

3.  P2Y2 receptor activates nerve growth factor/TrkA signaling to enhance neuronal differentiation.

Authors:  David B Arthur; Katerina Akassoglou; Paul A Insel
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

Review 4.  Pharmacogenetics in model systems: defining a common mechanism of action for mood stabilisers.

Authors:  Robin S B Williams
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2005-07       Impact factor: 5.067

Review 5.  Physiological roles of glycogen synthase kinase-3: potential as a therapeutic target for diabetes and other disorders.

Authors:  J R Woodgett
Journal:  Curr Drug Targets Immune Endocr Metabol Disord       Date:  2003-12

6.  A cAMP and CREB-mediated feed-forward mechanism regulates GSK3β in polycystic kidney disease.

Authors:  Vijayakumar R Kakade; Shixin Tao; Madhumitha Rajagopal; Xia Zhou; Xiaogang Li; Alan S L Yu; James P Calvet; Pankaj Pandey; Reena Rao
Journal:  J Mol Cell Biol       Date:  2016-05-04       Impact factor: 6.216

7.  Glycogen synthase kinase-3 is required for efficient Dictyostelium chemotaxis.

Authors:  Regina Teo; Kimberley J Lewis; Josephine E Forde; W Jonathan Ryves; Jonathan V Reddy; Benjamin J Rogers; Adrian J Harwood
Journal:  Mol Biol Cell       Date:  2010-06-09       Impact factor: 4.138

8.  Functional studies of shaggy/glycogen synthase kinase 3 phosphorylation sites in Drosophila melanogaster.

Authors:  Deppie Papadopoulou; Michele Wolfe Bianchi; Marc Bourouis
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

9.  The in vivo activity of Ime1, the key transcriptional activator of meiosis-specific genes in Saccharomyces cerevisiae, is inhibited by the cyclic AMP/protein kinase A signal pathway through the glycogen synthase kinase 3-beta homolog Rim11.

Authors:  Ifat Rubin-Bejerano; Shira Sagee; Osnat Friedman; Lilach Pnueli; Yona Kassir
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

10.  Glycogen Synthase Kinase 3 influences cell motility and chemotaxis by regulating PI3K membrane localization in Dictyostelium.

Authors:  Tong Sun; Bohye Kim; Lou W Kim
Journal:  Dev Growth Differ       Date:  2013-09-16       Impact factor: 2.053

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.